St. Louis-based biotech firm C2N Diagnostics gets $10M investment from Samsung
A St. Louis-based company known for its work in Alzheimer's and neurological testing can expand its footprint, thanks to a ...
Samsung Invests in C2N Diagnostics
C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today ...
Fierce Biotech4 天
Samsung backs Alzheimer's blood test developer C2N Diagnostics with $10M
Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial ...
Morningstar5 天
Samsung Invests in C2N Diagnostics
it has contributed to the stabilization of the biopharmaceutical supply chain and better access to high quality bio pharmaceutics. The investment into C2N Diagnostics shows Samsung’s continued ...
The Korea Herald4 天
Samsung invests $10m in US Alzheimer’s diagnostics firm C2N
Samsung C&T announced Thursday that its Life Science Fund, established in collaboration with Samsung Biologics, Samsung Bioepis and Samsung Venture Investment, will invest $10 million in C2N ...